Routine coronary computed tomography (CCT)-based follow-up after percutaneous coronary intervention (PCI) of the left main coronary artery did not reduce death, myocardial infarction (MI), unstable ...

Noninferiority was not demonstrated for death and ischemic events between P2Y12 inhibitor monotherapy and dual antiplatelet therapy (DAPT) given for 12 months after stenting in patients with acute ...

Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary syndrome (CCS) who had prior stenting and were receiving long-term ...

Routine coronary computed tomography (CCT)-based follow-up after percutaneous coronary intervention (PCI) of the left main coronary artery did not reduce death, myocardial infarction (MI), unstable ...

Medical device suppliers halt deliveries to Kerala government hospitals over ₹158.7 crore unpaid bills, urging prompt intervention for resolution.

Bill Clinton, 79, was recently seen in the Hamptons with someone carrying a device resembling a portable defibrillator, raising concerns about his hea ...

Aspirin, long the go-to for heart protection, may be dethroned. New research reveals clopidogrel, a blood thinner, reduces major cardiovascular events ...

In patients with chronic coronary syndrome on long-term oral anticoagulation, use of aspirin was linked with increased risk for ischemic events, bleeding and death, researchers reported at the ...

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...

Key take-awaysThe optimal antiplatelet therapy strategy is not well established in patients who are at high risk of ischaemic events, such as heart ...

Key take-awaysFor patients with left main coronary artery disease treated with percutaneous coronary intervention (PCI), the optimal surveillance ...

Type of device used in percutaneous coronary intervention †.. 0·35 Second-generation drug-eluting stent 9407/10 016 (93·9%) 9404/10 024 (93·8%). First-generation drug-eluting stent 90/10 016 (0·9%) ...